HADHB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.96349619791181E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.72750702631674E-12 |
Normal-vs-Stage2 |
1.028070E-04 |
Normal-vs-Stage3 |
2.79460000029985E-07 |
Normal-vs-Stage4 |
3.220800E-03 |
Stage1-vs-Stage2 |
5.085800E-01 |
Stage1-vs-Stage3 |
9.976000E-01 |
Stage1-vs-Stage4 |
5.836800E-01 |
Stage2-vs-Stage3 |
5.510600E-01 |
Stage2-vs-Stage4 |
3.698600E-01 |
Stage3-vs-Stage4 |
6.127400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.64346314335262E-12 |
Normal-vs-AfricanAmerican |
2.86869972221382E-10 |
Normal-vs-Asian |
4.273800E-01 |
Caucasian-vs-AfricanAmerican |
5.048400E-01 |
Caucasian-vs-Asian |
4.667200E-01 |
AfricanAmerican-vs-Asian |
5.486200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.21724893790088E-15 |
Normal-vs-Female |
3.34309999683313E-08 |
Male-vs-Female |
1.807630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.80420123285785E-11 |
Normal-vs-Extreme_Weight |
1.62503344114384E-12 |
Normal-vs-Obese |
1.0389999971494E-08 |
Normal-vs-Extreme_Obese |
1.860610E-01 |
Normal_Weight-vs-Extreme_Weight |
8.964800E-01 |
Normal_Weight-vs-Obese |
2.190400E-01 |
Normal_Weight-vs-Extreme_Obese |
1.896020E-01 |
Extreme_Weight-vs-Obese |
1.058560E-01 |
Extreme_Weight-vs-Extreme_Obese |
1.701430E-01 |
Obese-vs-Extreme_Obese |
3.004400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.177100E-03 |
Normal-vs-Age(41-60Yrs) |
1.72906133855122E-12 |
Normal-vs-Age(61-80Yrs) |
2.02171612784241E-13 |
Normal-vs-Age(81-100Yrs) |
2.11609999967166E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.138800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.015200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.086000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.004200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.981600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.214200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.77395900588817E-15 |
Normal-VS-Type2 PRCC |
2.46180000051943E-07 |
Normal-VS-KIRP CIMP |
9.277400E-03 |
Normal-VS-Unclassified PRCC |
4.42199999950432E-08 |
Type1 PRCC-VS-Type2 PRCC |
3.835500E-02 |
Type1 PRCC-VS-KIRP CIMP |
8.750000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
7.598800E-01 |
Type2 PRCC-VS-KIRP CIMP |
5.105400E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.729800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
9.875400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.388799990096E-09 |
Normal-vs-N1 |
8.3924000005009E-07 |
Normal-vs-N2 |
8.4525000000002E-05 |
N0-vs-N1 |
6.613200E-01 |
N0-vs-N2 |
6.877600E-01 |
N1-vs-N2 |
8.371800E-01 |
|
|